Navigation Links
Two Roche Women Honored as 2008 Tribute to Women and INdustry Awardees
Date:5/2/2008

NUTLEY, N.J., May 2 /PRNewswire/ -- Two Roche employees were recognized for their significant contributions to industry in New Jersey at the 34th Annual TWIN Awards Dinner held May 1, 2008. Honored were Jennifer Dudinak, Pharm.D., group director, Oncology, Drug Regulatory Affairs, and Sherrie Pietranico-Cole, Ph.D., research leader, Discovery Chemistry.

"These individuals exemplify the best and brightest at Roche. They have made outstanding contributions to the company's success, and to the health care industry as a whole," said George Abercrombie, president and CEO of Hoffmann-La Roche Inc., adding that the 2008 awardees join the 79 Roche pharmaceutical employees recognized since TWIN began 34 years ago.

TWIN, which stands for Tribute to Women and INdustry, is sponsored by the YWCA of Bergen County to recognize women who have achieved responsible managerial, executive or professional positions and have made noteworthy contributions to their industries.

The Awardees

Jennifer Dudinak, Pharm.D., is group director of Oncology in Drug Regulatory Affairs, which is the key interface between Roche and health authorities, such as the U.S. Food and Drug Administration (FDA). She leads a team responsible for overseeing the regulatory approval process for promising new cancer drugs or new indication on existing drugs that have completed the clinical trial phase. She also was recently appointed as the Pharmaceutical Development Regulatory (PDR) Partner to the company's Oncology Disease Biology Area team.

"Other TWIN winners have been tremendous role models for me, so to receive this award is very humbling," she said.

Dr. Dudinak joined Roche in 1997 as part of the Roche/Rutgers Post-Doctoral Fellowship Program and in 1999 became part of the PDR management team. She has worked in all phases of drug development leading several investigational new drug and global dossiers for new and supplemental indications. She also served as Inte
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Roche Research Director Grace Ju Hailed as NJABR Outstanding Woman of Science
2. MacroChem Acquires Virium Pharmaceuticals
3. Rochester Medical Announces Second Quarter 2008 Earnings Conference Call April 29, 2008
4. Roche Molecular Diagnostics Invests $57.5 Million in Green Research Building
5. MacroChem Appoints David P. Luci as New CFO
6. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
7. Roche to Acquire Ventana for $89.50 per share
8. Roche Extends Tender Offer for Ventana
9. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
10. Roche Files IND for Second Genmab Antibody
11. Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2008)... money on home medical and wellness .... 15 /- VidaCura, Incorporated,today...lness store,VidaCura.com. VidaCura.com provides a...ess products along with information and insurance,...ove their health and,learn how they can manage med...
(Date:10/15/2008)... and business development flexibility, TSX Exchan...tCall/ - Resverlogix Corp.,("Resverlogix") (TSX:RV...lion or approximately 60% of its remaining USD$17.... and CEO of Resverlogix stated, "The,economic envi...companies,around the globe. This action limits our...
(Date:10/15/2008)...ael, October 15 /-,Simbionix USA Corp... Series,C round of growth capital financing led by...investor Early Stage Partners and other existing,s...ho served as the,company,s investment bankers. The...e already rapid growth of its medical simulation t...
(Date:10/15/2008)...e-FirstCall/ -- Cryo-Cell,International, Inc. (OTC...,world,s largest and most established family cord ... quarter and nine months ended August 31,2008., ...pproximately $4.5,million compared to approximatel...Company reported a net loss in the third quarter 2...
Breaking Biology Technology:In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance 2Resverlogix Eliminates Sixty Percent of Remaining Debt 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 2Simbionix Raises Largest Amount in Company's History in Venture Capital to Accelerate Growth 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 2Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 3Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 4Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 5Cryo-Cell International, Inc. Reports Third Quarter 2008 Results 6
...San Diego - A company that uses Medical College o...logical expertise has been awarded $2.5 million fo...nia. , ,The company, Nanogen, Inc., said the res...ars, would enable it to develop improved molecular...d demonstrate the performance of this new molecula...
... Madison, Wis. - It,s not surprising that Gov. J...ill at odds over how the state,s latest budget wil...Doyle thinks he saved K-12 districts from cuts wit...yle abused his veto power and put more spending on...r public education appears destined never to be se...
...MILWAUKEE -- Marshall & Ilsley Corp . announced ...th Plansmith Corp . of Schaumburg, Ill., to expan... ,With the partnership, M&I will use Plansmith,s C...ware to assist financial institutions in their pro...,M&I began offering a planning assistance program ...
... An entry to a consumer,s house in any foreign lan...re was this product born? What,s its true national...today? What,s the bearer,s nation done for my nati...o secret that consumers all over the world are far...o. They clearly support or oppose their own countr...
Other Biology Technology:Before deciding how to pay for K-12 schools, let's determine what to buy 2Before deciding how to pay for K-12 schools, let's determine what to buy 3Why are brands culturally profiled? 2Why are brands culturally profiled? 3
(Date:10/14/2008)..., The gecko,s amazing ability to stick to surfaces...o manufacture materials that mimic the special sur...o,s ability to stick so well is a forest of pillar... gecko,s foot. Because there are so many pillars s...face the gecko is walking on by a molecular force ...
(Date:10/14/2008)... Infection is the leading cause of infant deaths ...ker, pre-term infants. Current diagnostic tests ca...ow identified potential biomarkers in the blood th...n and type of microbe. , The circulatory system...tephen Kingsmore and colleagues analyzed plasma sa...
(Date:10/14/2008)...tics researchers have identified two novel gene lo... they continue to reveal pieces of the complicated...expect to improve predictive tests and devise prev... of the biology of type 1 diabetes and better unde...ill be able to develop better diagnostic tests tha...
(Date:10/14/2008)...ADELPHIAThe National Institutes of Health has awar...an scientists, including The Academy of Natural Sc...nd biofuels technology from marine mollusks for de...concentrated in the Philippine archipelago, whose ... mollusk speciesabout a fifth of all the known spe...
Breaking Biology News(10 mins):Researchers continue to find genes for type 1 diabetes 2Academy participates in project to discover drugs, biofuels in tropical seas 2Perr 26Knight Announces Discounted Fee Schedule for Access to Its Online Database of Commercial Lines Competitor Filings 17456 1Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 17452 1Symposium at Angioplasty Summit TCT Asia Pacific 2008 Features OrbusNeichs Genous 28TM 29 Bio engineered R stent 28TM 29 17452 2Orchard Supply Hardware Partners With Canary Foundation 17448 1Orchard Supply Hardware Partners With Canary Foundation 17448 2Orchard Supply Hardware Partners With Canary Foundation 17448 3Elusys Anthim 28TM 29 Dramatically Improves Survival of Animals Treated After Active Anthrax Infection 4776 1Elusys Anthim 28TM 29 Dramatically Improves Survival of Animals Treated After Active Anthrax Infection 4776 2Elusys Anthim 28TM 29 Dramatically Improves Survival of Animals Treated After Active Anthrax Infection 4776 3
...ngton University in St. Louis have made an importa...ells take to silence unwanted or extra genes using...ossible to see where, and how, the events in the p...ving, as the old saying goes. , Craig Pikaa...ogy in Arts & Sciences and his collaborators h...
...lose oneself" in an experience? Many theoretical m...at awareness is dependent on the mediation of area...f-aware "observer" network ?in the human brain. , ...el of the Weizmann Institute,s Neurobiology Depart...uestion ?by scanning the brains of volunteers perf...
...f bacteria -- the way they get a foothold in plant...cording to research published this week by Michiga...he bacterial pathogen Pseudomonas syringae, better...e pathogen reared its speckled head in tomatoes, c...describes using P. syringae in the laboratory plan...
... that dynamic regions of the human genome -- "hots...e potentially involved in the rapid evolution of m...re genetically determined. , Now, an international... and an associate professor from Arizona State Uni...es, which has implications for the understanding o...
Other Biology News:Pathway toward gene silencing described in plants 2Pathway toward gene silencing described in plants 3Pathway toward gene silencing described in plants 4Lost in thought: Brain research 2Chimpanzee study reveals genome variation hotspots 2
Rabbit polyclonal to Presenilin 1, prediluted ( Abpromise for all tested applications). entrezGeneID: 5663 SwissProtID: P49768
ROCK-1 (cleaved) Monoclonal Ab 100 ug purified mouse monoclonal antibody. Clone# 12M03. Reacts with human. Tested in Western blot analysis.
Mouse monoclonal [LPL4A.1] to Plastin L ( Abpromise for all tested applications). SwissProtID: P13796
Mouse monoclonal [CAT-1] to Chloramphenicol Acetyltransferase ( Abpromise for all tested applications).
Biology Products: